| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $14.9M | +30.3% | +196.0% |
| SG&A Expense | $21.4M | +29.1% | +195.4% |
| Operating Income | -$36.3M | -29.6% | -195.6% |
| Pre-tax Income | -$29.2M | -20.4% | -199.9% |
| Income Tax | $531K | +23.2% | +136.0% |
| Net Income | -$29.7M | -20.4% | -198.4% |
| EPS (Basic) | -$0.20 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $410.0M | +80.8% | +346.7% |
| Current Assets | $931.8M | +71.7% | +296.8% |
| Total Assets | $1.25B | +70.5% | +324.2% |
| Current Liabilities | $13.8M | +81.3% | +184.8% |
| Total Liabilities | $40.6M | +17.2% | +33.1% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$48.7M | — | — |
| Capital Expenditures | $6.3M | — | — |
| Investing Cash Flow | -$605.9M | — | — |
| Financing Cash Flow | $967.6M | — | — |
| Free Cash Flow | -$55.0M | — | — |
| -11.1% |
| -150.0% |
| EPS (Diluted) | -$0.20 | -11.1% | -150.0% |
| $1.21B |
| +73.1% |
| +357.9% |